ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.830
-0.030 (-1.61%)
At close: Apr 28, 2026, 4:00 PM EDT
1.860
+0.030 (1.64%)
After-hours: Apr 28, 2026, 5:15 PM EDT
ProKidney Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ProKidney stock have an average target of 7.40, with a low estimate of 1.00 and a high estimate of 12. The average target predicts an increase of 304.37% from the current stock price of 1.83.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 16, 2025.
Analyst Ratings
The average analyst rating for ProKidney stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +555.74% | Dec 16, 2025 |
| UBS | UBS | Strong Buy Maintains $4 → $8 | Strong Buy | Maintains | $4 → $8 | +337.16% | Jul 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +282.51% | Jul 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +391.80% | Jul 9, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $3 → $1 | Hold → Sell | Downgrades | $3 → $1 | -45.36% | Jun 30, 2025 |
Financial Forecast
Revenue This Year
309.74K
from 893.00K
Decreased by -65.31%
Revenue Next Year
291.72K
from 309.74K
Decreased by -5.82%
EPS This Year
-0.59
from -0.52
EPS Next Year
-0.71
from -0.59
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 840,000 | 840,000 | ||||||
| Avg | 309,743 | 291,720 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -5.9% | 171.2% | ||||||
| Avg | -65.3% | -5.8% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.53 | -0.44 | ||||||
| Avg | -0.59 | -0.71 | ||||||
| Low | -0.70 | -1.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.